PensionDanmark Pensionsforsikringsaktieselskab increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 7.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 458,585 shares of the company’s stock after acquiring an additional 31,022 shares during the quarter. Procter & Gamble comprises about 0.6% of PensionDanmark Pensionsforsikringsaktieselskab’s investment portfolio, making the stock its 29th largest holding. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Procter & Gamble were worth $67,247,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. grew its position in Procter & Gamble by 1,000.0% during the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock worth $25,000 after buying an additional 150 shares in the last quarter. Park Square Financial Group LLC grew its holdings in shares of Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after purchasing an additional 71 shares in the last quarter. Evolution Wealth Management Inc. raised its stake in Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares in the last quarter. Litman Gregory Wealth Management LLC bought a new stake in Procter & Gamble during the fourth quarter worth about $26,000. Finally, Maseco LLP bought a new position in Procter & Gamble in the 4th quarter valued at about $28,000. Institutional investors own 65.77% of the company’s stock.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Thorne acquisition expands growth opportunities. P&G agreed to acquire science-focused supplements company Thorne for approximately $3.8 billion. The deal broadens PG’s health-care portfolio into vitamins, minerals and supplements, a faster-growing category that could diversify its traditional household and personal-care businesses. Procter & Gamble Agrees To Buy Thorne For $3.8 Billion
- Positive Sentiment: Investors initially viewed the deal favorably. Market coverage described the acquisition as a reason PG stock moved higher, suggesting investors see strategic value in Thorne’s premium positioning and potential to support longer-term growth. A $3.8 Billion Reason Why Procter & Gamble Stock Is in Focus Today
- Positive Sentiment: Sustainability progress may support brand relationships. PureCycle Technologies reported that first P&G commercial resin deliveries began, with select Downy detergent caps entering commercial production. The development supports PG’s recycled-material goals and may help strengthen sustainability credentials, although the direct financial impact appears limited for now. PureCycle Technologies Reports Second Quarter 2026 Results
- Neutral Sentiment: Acquisition execution and valuation remain key questions. The $3.8 billion purchase is sizable relative to P&G’s historical acquisitions, so investors will likely focus on the price paid, funding, integration and how quickly Thorne contributes to earnings. See how P&G’s $3.8B Deal for Thorne Compares With Its Past Acquisitions
Procter & Gamble Trading Down 0.0%
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same period in the prior year, the company earned $1.48 EPS. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s dividend payout ratio is presently 65.71%.
Analyst Ratings Changes
A number of analysts have recently weighed in on PG shares. UBS Group upped their price target on shares of Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a report on Monday, April 27th. Piper Sandler boosted their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research report on Friday, April 24th. HSBC restated a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Bank of America reduced their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research note on Wednesday, June 24th. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $161.52.
View Our Latest Research Report on PG
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
